Navigation Links
Anti-Cancer Drug Restores Normal Cell Growth

An experimental anti-cancer drug has shown effectiveness in treating a resistant type of lymphoma, according to a new report. Researchers say the drug probably acts on many types of cancer cells, so it may be useful for treating other types of cancer. Dr. Antonio Fojo of the National Cancer Institute in Bethesda, Maryland, and colleagues tested the drug, depsipeptide//, in patients with T-cell lymphoma, a cancer of the lymphatic system that rarely responds to chemotherapy.

Depsipeptide is a member of a class of drugs known as histone deacetylase inhibitors. Fojo and colleagues believe these drugs may help restore normal growth to cancer cells, which typically arise from normal cells in which growth regulation has gone awry.

The drug's side effects were comparable to those seen with other types of chemotherapy and included fatigue, nausea and vomiting, lowered platelet count and abnormal heart rhythm, the researchers add. "These results suggest that is a novel and potentially effective therapy for patients with T-cell lymphoma," Fojo's team concludes.


'"/>




Page: 1

Related medicine news :

1. FDA Approves Anti-Cancer Cell Drug - Zevalin
2. Compounds Found In The Vegetable Broccoli Could Have Anti-Cancer Properties
3. Premature Aging Can Be Managed With Anti-Cancer Drugs In Future
4. Antidepressant Drug Found To Have Anti-Cancer Effects
5. Colgate To Develop Anti-Cancer Toothpastes And Mouthwashes
6. Clinical Trials Of New Anti-Cancer Drug To Be Initiated In New Zealand
7. Small Cars, Anti-AIDS And Anti-Cancer Drugs Would Be Cheaper
8. Anti-Cancer Treatment Promises Hope in Bird Flu Treatment
9. Exercise Has An Anti-Cancer Effect
10. A New Anti-Cancer Drug Keeps Resistance Out
11. A New Approach towards Anti-Cancer Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/17/2019)... ... September 17, 2019 , ... Dr. ... he has been certified by the American Academy of Facial Esthetics (AAFE) to ... a wide range of orofacial conditions such as tooth clenching and grinding, tongue ...
(Date:9/17/2019)... ... September 17, 2019 , ... CORE Medical & Wellness, a ... Gartshteyn to their team of expert physicians. Dr. Gartshteyn completed her Rheumatology Clinical ... of Assistant Professor in Medicine for the Division of Hospitalist Medicine. , Dr. ...
(Date:9/12/2019)... ... 2019 , ... Donaldson Plastic Surgery & Aesthetic Solutions has ... well-renowned listing publications, the Inc. 5000 and Columbus’s Fast 50, highlighting the practice ... Dr. Jeffrey Donaldson, CEO and owner of Donaldson Plastic Surgery & Aesthetic Solutions, ...
(Date:9/11/2019)... ... September 11, 2019 , ... Global ... continuing medical education (CME) provider, is the official accreditor for PAINWeek, the largest ... speakers, and screened topics, as it has done for the past ten years. ...
(Date:9/11/2019)... ... September 11, 2019 , ... Autopsies don’t lie. They report the causes ... , Methamphetamine permanently harms the heart. It increases risks of heart attack and ... of how the damage occurs. , An August 1, 2019 article in ...
Breaking Medicine News(10 mins):
(Date:9/18/2019)... ... September 18, 2019 , ... NDA Partners Chairman ... well-respected preclinical drug development expert with a focus in the cardiovascular and metabolic ... to joining NDA Partners, Dr. Hoffmann served as Executive Director of Preclinical Safety ...
(Date:9/17/2019)... New Zealand (PRWEB) , ... September 17, 2019 , ... ... in in Fast Company’s 2019 Innovation by Design Awards Students category. , It was ... at the Auckland Bioengineering Institute. , Muss-Bits is comprised of two parts. A “sensor ...
(Date:9/17/2019)... ... 2019 , ... Scientists writing in a 2017 issue of ... progressive destruction of joint cartilage in osteoarthritis are “on the close horizon.” ... orthopedic surgeon Alejandro Badia, MD , founder and chief medical officer of ...
Breaking Medicine Technology: